Antidepressants are significantly more effective than placebo in adults with major depression, research suggests.
The behavioral health foundation of Providence St Joseph Health has announced its first three recipients of grants from its $100 million fund aimed at improving mental health treatment access and outcomes.
A Class II recall is ongoing for an antipsychotic because of a labeling error.
The US Food and Drug Administration has approved a new 2-month dose of an extended-release injectable atypical antipsychotic.
Recent research found that patients report side effects after switching from a brand-name medication to a generic when the drugs are chemically identical.